Drug name - Prevacid Iv

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7396841

(Pediatric)

TAKEDA PHARMS NA Injections
Feb, 2022

(9 months ago)

Drugs and Companies using LANSOPRAZOLE ingredient

Market Authorisation Date: 27 May, 2004

Treatment: NA

Dosage: INJECTABLE;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
30MG/VIAL INJECTABLE;INTRAVENOUS Discontinued

availability in other generic markets.

Click on the highlighted region to filter.